
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+14
Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics to enable earlier and more equitable diagnosis and treatment of behavioral health conditions, starting with autism. We are dedicated to improving lifelong outcomes for children at risk for developmental delay and their families. Our lead products, the first digital diagnostic device for autism and the first digital therapeutic for children diagnosed with autism, have both received Breakthrough Device designation from the FDA. Cognoa plans to commercialize Canvas DxTM, the first FDA authorized diagnostic device for autism, for U.S. availability beginning in 2023. The companys AI technology platform will...
Machine learning,digital therapeutics,prescription digital therapeutics,medtech,med device,diagnostics,healthtech,ai,behavioral health,early childhood developmental health,early childhood development,developmental health,mental health,digital health,digital diagnostics,early intervention,pediatrics,pediatric mental health,and pediatric behavioral health
Cognoa operates in the Hospitals and health care industry.
Cognoa's revenue is 11m - 100m
Cognoa has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.